McKenna Mark C. (CIK 1749623) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-01-09). Recent activity: Buy NAMS (3,400 shares), Buy BBOT (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-09 | NewAmsterdam Pharma Co N.V. (NAMS) | Director | Buy | 3,400 | $0 |
| 2025-08-11 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Insider | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-01-09